1248 GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HCV RESISTANCE FROM A MULTIPLE DOSE CLINICAL TRIAL OF GS-9451, A NOVEL NS3 PROTEASE INHIBITOR